Early diagnosis and treatment of malignant tumors improve the diagnosis and facilitate the clinical recovery.

Patients with anti-hu antibodies were found to have a poor prognosis and multifocal neurological symptoms, and patients with anti-Ta antibodies were found to have a poor prognosis,Â but patients who do not have autoantibodies in their blood appear to have a better prognosis.

Patients with anti-GABA B receptor may respond to immunosuppressant drugs better than patients with anti-hu patients.